Brought to you by 
Emphasys Medical closes $18.4mm Series E round
17 Aug 2006
Executive Summary
Interventional pulmonary company Emphasys Medical (minimally invasive devices for COPD) raised $18.4mm in a Series E preferred stock financing. New investor Cargill Ventures led the round, which included new backer Trellis Health Ventures and returning buyers ABS Ventures, Advanced Technology Ventures, Morgenthaler Ventures, Morgan Stanley Venture Partners, OrbiMed Advisors, and Split Rock Partners. The company will use the money to fund regulatory filings and launch its Zephyr endobronchial valve for advanced emphysema.
Deal Industry
- Medical Devices
-
Medical Devices
- Implantable Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Emphasys Medical closes $18.4mm Series E round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice